GlassScriptPhysician profile
Sara Glendinning
NPI 1659064632
$1,830.21
in general payments reported to CMS, 2019-2025
9 companies · $557 in 2025
The $557 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $493 · 2024: $780 · 2025: $557.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,781 · Education: $49.20.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,781.01 |
| Education | $49.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $370.26 | 2023-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Kerecis Limited | $356.77 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Medtronic, INC. | $225.51 | 2023-2024 | Signia, Ligasure |
| Acera Surgical, INC. | $186.30 | 2024 | Restrata Wound Matrix |
| Intuitive Surgical, INC. | $165.84 | 2024 | |
| Axonics, INC. | $153.77 | 2023 | Axonics |
| My01 INC. | $145.37 | 2023 | My01 Continuous Compartmental Pressure Monitor |
| Integra Lifesciences Corporation | $142.78 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Organogenesis INC. | $83.61 | 2025 | Puraply Wound Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Glendinning listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.